Business Standard

Dr Reddy's gets USFDA nod for anti-nausea drug

Image

Our Web Bureau Mumbai
Dr Reddy's gets USFDA nod for anti-nausea drug
Our Web Bureau / Mumbai December 27, 2006
Dr. Reddys Laboratories has been granted final approval by the US Food and Drug Administration (USFDA) for the abbreviated new drug application (ANDA) of Ondansetron Hydrochloride Tablets, 4mg, 8mg, 16mg and 24mg.

Ondansetron Hydrochloride Tablets are the AB-rated generic equivalent of GSK's Zofran

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 27 2006 | 6:45 PM IST

Explore News